e-learning
resources
Barcelona 2013
Monday, 09.09.2013
COPD mechanisms
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Plasma osteoprotegerin is related to femoral osteoporosis in patients with COPD
P. Pobeha, D. Petrasova, R. Tkacova, P. Joppa (Kosice, Slovakia)
Source:
Annual Congress 2013 –COPD mechanisms
Session:
COPD mechanisms
Session type:
Thematic Poster Session
Number:
2141
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Pobeha, D. Petrasova, R. Tkacova, P. Joppa (Kosice, Slovakia). Plasma osteoprotegerin is related to femoral osteoporosis in patients with COPD. Eur Respir J 2013; 42: Suppl. 57, 2141
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Serum leptin, adponectin and its tissue expression in COPD patients with osteopenic syndrome
Source: International Congress 2015 – COPD: notable points
Year: 2015
Osteoporosis and adipose tissue expression of adipokines and osteoprotegerin in severe chronic obstructive pulmonary disease
Source: Annual Congress 2013 –COPD: acute exacerbations and others
Year: 2013
Inflammatory markers (IL-6, suPAR) and arterial stiffness parameters in COPD patients
Source: International Congress 2016 – Biomarkers and phenotypes of COPD
Year: 2016
Serum levels of RAAS components in COPD
Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease
Year: 2015
Elevated circulating CTLA-4 level in patients with COPD is related to systemic inflammation and disease severity
Source: Annual Congress 2013 –COPD: markers and inflammation
Year: 2013
Serum sirtuin-1 is reduced in COPD
Source: International Congress 2016 – Systemic biomarkers
Year: 2016
Increased serum level of apelin in chronic obstructive pulmonary disease
Source: International Congress 2015 – COPD: interesting notes
Year: 2015
The potential value of FRAX index and bone turnover markers to identify osteoporosis in COPD patients
Source: International Congress 2015 – Monitoring and phenotyping COPD
Year: 2015
Serum levels of leptin and visfatin in chronic obstructive pulmonary disease
Source: International Congress 2015 – Different data in COPD
Year: 2015
Microparticles in stable and exacerbated COPD patients
Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations
Year: 2013
Study of bone mineral density, hemogram and their correlations in patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – Respiratory disease within hospital-based populations
Year: 2014
Systemic inflammatory markers in COPD: results from the Bergen COPD Cohort Study
Source: Eur Respir J 2010; 35: 540-548
Year: 2010
Systemic inflammation in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2013 –COPD diagnosis
Year: 2013
The relationship between systemic inflammation and vitamin D levels in COPD
Source: Annual Congress 2013 –Factors associated with outcomes in COPD
Year: 2013
Plasma surfactant protein D (SP-D) and nutritive status in patients with COPD
Source: Annual Congress 2013 –COPD treatment and others
Year: 2013
Circulating desmosine relates to cardiovascular comorbidity, coronary artery calcification score (CACS), systemic inflammation and mortality in patients with COPD
Source: International Congress 2014 – Molecular pathogenesis of pulmonary inflammatory diseases (COPD, asthma and ILD)
Year: 2014
Influence of systemic inflammation and hypoxaemia on bone metabolism in patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2013 –COPD diagnosis
Year: 2013
Obesity and bone health in COPD
Source: Annual Congress 2013 –The best posters in chronic care
Year: 2013
Comparison of osteoporosis in male smokers with or without COPD
Source: International Congress 2016 – Smoking-related diseases
Year: 2016
COPD, an inflammatory systemic disease. Inflammatory parameters in a group of COPD patients
Source: International Congress 2014 – Lung function, COPD and inflammation
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept